Clinical Trial Update: Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on safety, antiviral activity, and pharmacokinetics of BI 201335 in treatment-naïve and experienced chronic hepatitis C patients; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BI 201335

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2015-09-17